Zanamivir is a topic covered in the
Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --
INDICATIONS
- Uncomplicated acute illness due to influenza A and B infection (patients > 7 yrs of age with < 48hr symptoms).
- Influenza prophylaxis in those 5 years of age or older.
- Not proven effective for prophylaxis in nursing home residents.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
- Uncomplicated acute illness due to influenza A and B infection (patients > 7 yrs of age with < 48hr symptoms).
- Influenza prophylaxis in those 5 years of age or older.
- Not proven effective for prophylaxis in nursing home residents.
There's more to see -- the rest of this entry is available only to subscribers.
Last updated: December 6, 2017
TY - ELEC
T1 - Zanamivir
ID - 540596
A1 - Pham,Paul,Pharm.D.
Y1 - 2017/12/06/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540596/all/Zanamivir
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -